Page 433 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 433

354    Part IV  Disorders of Hematopoietic Cell Development

        Pathophysiology                                       Decreased colony numbers in these studies can be interpreted as the
                                                              result of an absolute decrease in progenitors and/or progenitors that
        Wild-type  FA  proteins  are  part  of  a  cluster  of  survival  signaling   have faulty proliferative properties and cannot form colonies in vitro.
        molecules that protect against genotoxic insult and suppress apoptosis   Additional  factors  are  operative  in  FA  BM  failure.  Telomeres,
        signaling.  With  inactivation  of  any  of  the  known  FA  genes,  the   the nonencoding DNA at each end of chromosomes, shorten with
        prosurvival benefit is lost. This underlies the phenotype of clinical   each  round  of  cell  division  in  normal  human  somatic  cells. Their
        FA but does not explain or unify the relationship among congenital   length is a reflection of the mitotic history of the cell. Telomerase,
        anomalies, BM failure, the predisposition to cancer, and chromosome   a  ribonucleoprotein  reverse  transcriptase  that  can  restore  telomere
        fragility.                                            length, is variably present in hematopoietic progenitors. Leukocyte
           Two theories of the pathophysiology of FA relate to either (1) a   telomere  length  is  significantly  shortened  in  patients  with  FA  but
        heightened  sensitivity  to  oxygen,  resulting  in  cell  damage;  or  (2)   there  is  increased  telomerase  activity,  suggesting  an  abnormally
        defective DNA repair. The oxygen sensitivity phenotype of FA cells   high  proliferative  rate  of  progenitors  that  ultimately  leads  to  their
        is  characterized  by  overproduction  of  oxygen  radicals,  a  deficient   premature senescence. In parallel, increased BM cell apoptosis has
        oxygen  radical  defense,  a  deficiency  in  superoxide  dismutase,  and   been  demonstrated  in  patients  with  FA  and  in  knock-out  mouse
        poor  cell  growth  at  ambient  oxygen,  all  producing  shortened  cell   models and is mediated by Fas, a membrane glycoprotein receptor
        survival. A cardinal phenotype of FA cells is an abnormality in cell   containing an integral death domain. FA cells exposed to TNF-α,
        cycle distribution with an increased number of cells with 4N DNA   INF-γ,  MIP-1α,  Fas  ligand,  and  double-stranded  RNA  undergo
        content arising from a delay in the G 2/M or late S phase of the cell   exaggerated apoptotic responses.
        cycle.  The  strongest  evidence  supporting  an  oxygen  metabolism   Studies  of  cytokines  in  patients  with  FA  have  shown  varied
        deficiency in FA is a reduction of FA cells with 4N DNA content   abnormalities.  Although  FA  fibroblasts  showed  no  deficiencies  in
        when grown at low oxygen levels and the unexpected appearance of   SCF or macrophage colony-stimulating factor (M-CSF) production,
        4N DNA content when normal cells are grown at high oxygen levels.   variability  ranging  from  diminished  production  to  augmentation
        Of  note,  some  wild-type  FA  proteins  play  a  role  in  redox-related   of production of IL-6, GM-CSF, and G-CSF (granulocyte colony-
        functions. FANCC associates with NADPH (nicotinamide adenine   stimulating factor) has been observed in different patients. A consis-
        dinucleotide phosphate), cytochrome P-450 reductase, and glutathi-  tent finding that may relate directly to pathogenesis is diminished
        one  S-transferase,  proteins  with  redox  functions.  FANCA  and   IL-6 production in patients with FA and markedly increased TNF-α
        FANCG  are  redox-sensitive  proteins  that  multimerize  after  H 2 O 2    generation.
        treatment, prompting the notion that the FA pathway may function   Initial attempts to generate induced pluripotent stem cells (iPSCs)
        in oxidative stress management.                       from patients with FA have been difficult since reprogramming causes
           The best evidence supporting the theory that the primary defect   increased DNA double-stranded break and the FA pathway needs to
        is in DNA repair relates to the critical role of wild-type FANC pro-  be activated. This barrier can be bypassed by either correcting the
        teins  in  the  DNA  damage  response  pathway.  Whereas  clastogenic   genetic defect before reprogramming or performing the reprogram-
        bifunctional  cross-linker  agents  such  as  MMC  and  DEB  induce   ming under hypoxic conditions. Successful reprogramming resulted
        chromosomal breakage in FA cells, monofunctional chemical agents   in cells that recapitulate the hematopoietic defect and identify the
        do not, indicating that FA cells cannot repair interstrand cross-links.   early pathogenetic defect at the stage of hemoangiogenic progenitors.
        There were also experiments in the 1980s in which the frequency of
        mutations induced by 8-methoxypsoralen plus near-ultraviolet radia-
        tion at the HPRT locus was lower in FA cells than in control partici-  Clinical Features
        pants. These results indicated that FA cells cannot repair cross-links
        through the normal pathway involving mismatch repair, recombina-  History and Physical Examination
        tional repair after bypass of the lesion, or both. Additional evidence
        for  defective DNA  repair  in FA  cells  includes an  accumulation  of   The diagnosis of FA can readily be made based on signs and symp-
        DNA adducts, a failure to arrest DNA synthesis in response to DNA   toms  related  to  aplastic  anemia  and  the  presence  of  characteristic
        damage, increased homologous recombination, defective nonhomolo-  congenital physical anomalies. However, a study from the Interna-
        gous  end  joining,  abnormal  induction  of  p53,  and  increased   tional  Fanconi  Anemia  Registry  (IFAR,  Rockefeller  University),
        apoptosis.                                            which used confirmatory chromosomal breakage studies, showed that
           The two theories for the pathophysiology of FA can be reconciled   only 39% of patients with FA have both aplastic anemia and anoma-
        theoretically. It is possible that loss of any FA protein causes a transient   lies. The rest of the patients had aplastic anemia but no anomalies
        increase of oxidative damage to which the repair machinery is par-  (30%), anomalies but not aplastic anemia (24%), or neither (7%).
        ticularly sensitive.                                     Table 29.2 lists the characteristic physical abnormalities and their
                                                              approximate  frequency  based  on  more  than  2000  published  case
        Hematopoietic Dysfunction                             reports. The two most common anomalies are skin hyperpigmentation
        Hematologic abnormalities in FA are evident at the hematopoietic   and short stature, each with a frequency of 40% of cases. Characteristi-
        progenitor cell level in BM and peripheral blood. The frequencies   cally,  the  hyperpigmentation  is  a  generalized  brown  melanin-like
        of CFU-E (colony-forming unit-erythroid), BFU-E (burst-forming   splattering that is most prominent on the trunk, neck, and intertrigi-
        unit-erythroid),  and  CFU-GM  (colony-forming  unit-granulocyte   nous  areas  and  that  becomes  more  obvious  with  age.  Café-au-lait
        macrophage) colony-forming cells are reduced fairly consistently in   spots  are  common  alone  or  in  combination  with  the  generalized
        almost all patients after aplastic anemia ensues as well as in a few   hyperpigmentation  and  sometimes  with  vitiligo  or  hypopigmenta-
        patients before the onset of aplastic anemia. Although FA BM cells   tion.  The  skin  pigmentation  should  not  be  confused  with
        show  normal  transcripts  for  the  α  and  β  chains  of  the  GM-CSF   hemosiderosis-induced  bronzing  in  transfusion-dependent  patients
        (granulocyte  macrophage  colony-stimulating  factor)/interleukin-3   who  have  not  been  adequately  iron  chelated.  In  those  with  short
        (IL-3)  receptor  and  for  c-kit  protein,  there  is  a  deficient  prolif-  stature, most are less than the third percentile for height. In some
        erative response of CFU-GEMM (colony-forming unit granulocyte,   patients, growth failure is associated with endocrine abnormalities.
        erythrocyte,  macrophage,  megakaryocyte),  BFU-E,  and  CFU-GM   In one report, spontaneous overnight growth hormone secretion was
        progenitors to GM-CSF plus stem cell factor (SCF) (c-kit ligand)   abnormal in all patients tested, and 44% had a subnormal response
        or to IL-3 plus SCF. Because all hematopoietic lineages are affected,   to growth hormone stimulation. Approximately 40% of patients also
        the  basic  defect  is  presumed  to  be  at  the  HSC  level.  Cure  of  FA   have overt or compensated hypothyroidism, sometimes in combina-
        BM  failure  by  HSC  transplantation  (HSCT)  supports  this  view.   tion with growth hormone deficiency.
        Confirmatory data for defective stem cells in FA using long-term BM   Malformations involving the upper limbs are common, especially
        cultures were reported by one group but not confirmed by another.   hypoplastic, supernumerary, bifid, or absent thumbs. Hypoplastic or
   428   429   430   431   432   433   434   435   436   437   438